{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "N.D. (HGVS nomenclature standardization via API is not possible without specific transcript information in the provided text. However, based on the text, the cDNA and protein changes can be inferred as follows)",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S (a common mutation in the Mg²⁺ binding motif at the beginning of the activation loop of the kinase domain)"
        },
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "I",
            "alt": "T",
            "position": "2020"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "T",
            "position": "2020"
          },
          "Description in input context": "I2020T (mutation at the adjacent isoleucine in the original family reported to have autosomal dominant PD linked to this locus)"
        },
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "I",
            "alt": "V",
            "position": "1122"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "V",
            "position": "1122"
          },
          "Description in input context": "I1122V (mutation in the leucine - rich repeats)"
        },
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "R",
            "alt": "C",
            "position": "1441"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "C",
            "position": "1441"
          },
          "Description in input context": "R1441C (mutation in the Roc domain)"
        },
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "Y",
            "alt": "C",
            "position": "1699"
          },
          "Protein Change": {
            "ref": "Y",
            "alt": "C",
            "position": "1699"
          },
          "Description in input context": "Y1699C (mutation in the COR region)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease (PD)",
    "MONDO": "MONDO:0005149"
  },
  "Experiment Method": [
    {
      "Assay Method": "Constructs and cell culture",
      "Material used": {
        "Material Source": "Cell line/Animal model",
        "Material Name": "COS7, HEK293, SH - SY5Y cells, primary rat cortical neurons",
        "Description": "Full - length dardarin cDNA constructs were introduced into COS7, HEK293, SH - SY5Y cells using Fugene. Primary rat cortical neuron cultures were generated from E18 pups, transfected with constructs using Lipofectamine 2000."
      },
      "Readout type": "N.D.",
      "Readout description": [
        {
          "Variant": "G2019S",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "N.D."
        },
        {
          "Variant": "I2020T",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "N.D."
        },
        {
          "Variant": "I1122V",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "N.D."
        },
        {
          "Variant": "R1441C",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "N.D."
        },
        {
          "Variant": "Y1699C",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "N.D."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Expression of mutants was representative of data seen at least three experiments per construct."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Phosphorylation and kinase assays",
      "Material used": {
        "Material Source": "Mammalian cells",
        "Material Name": "Immunoprecipitated dardarin from mammalian cells",
        "Description": "Immunoprecipitated dardarin from mammalian cells was incubated in kinase reaction buffer containing ³²P - ATP."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "G2019S",
          "Conclusion": "Produced a small increase in autophosphorylation activity (P < 0.05)",
          "Molecular Effect": "N.D.",
          "Result Description": "Incorporation of radiolabel into the major band of >260 kDa representing GFP - tagged dardarin was higher compared to some other mutants"
        },
        {
          "Variant": "R1441C",
          "Conclusion": "Did not show an increase in autophosphorylation activity",
          "Molecular Effect": "N.D.",
          "Result Description": "Incorporation of radiolabel into the major band of >260 kDa representing GFP - tagged dardarin was not increased"
        },
        {
          "Variant": "Y1699C",
          "Conclusion": "Did not show an increase in autophosphorylation activity",
          "Molecular Effect": "N.D.",
          "Result Description": "Incorporation of radiolabel into the major band of >260 kDa representing GFP - tagged dardarin was not increased"
        },
        {
          "Variant": "Kinase - dead mutation",
          "Conclusion": "Deficient in autophosphorylation (P < 0.001 compared to wild type by one - way ANOVA)",
          "Molecular Effect": "N.D.",
          "Result Description": "Reduced incorporation of radiolabel into the major band of >260 kDa representing GFP - tagged dardarin"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Quantification was done from quadruplicate experiments."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "One - way ANOVA was used to analyze the autophosphorylation data."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Human brain Western blotting and immunohistochemistry",
      "Material used": {
        "Material Source": "Human brain tissue",
        "Material Name": "Human frontal cortex, midbrain sections from neurologically normal individuals and sporadic PD cases",
        "Description": "For Western blotting, protein extracts from human frontal cortex were used. For immunohistochemistry, 7μm fixed, wax - embedded tissue sections from two pathologically verified sporadic PD cases were used."
      },
      "Readout type": "N.D.",
      "Readout description": [
        {
          "Variant": "All variants (general)",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "Antibody NB300 - 267 recognized a band of approximately 260 kDa in human brain lysates. In midbrain sections, the antibody stained cell bodies and processes of midbrain melanized dopamine neurons in normal individuals and in sporadic PD cases. Dardarin immunoreactivity was seen in the halo of some Lewy bodies in sporadic PD cases."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "A scrambled shRNA was used as a negative control for LRRK2 knockdown in HEK cells."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Toxicity assays",
      "Material used": {
        "Material Source": "Cell line/Animal model",
        "Material Name": "SH - SY5Y cells, primary rat cortical neurons",
        "Description": "Full - length wild - type or mutant dardarin was transfected into SH - SY5Y cells. Primary rat cortical neurons were also transfected with constructs."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "Y1699C",
          "Conclusion": "Induced nuclear shrinkage, especially after 3 - 4 days post - transfection. Increased the number of transfected TUNEL - positive cells. Induced significant cell death (P < 0.001 by ANOVA compared to wild type).",
          "Molecular Effect": "N.D.",
          "Result Description": "Nuclear morphology changes were observed. Number of TUNEL - positive cells increased. Counts of cells with intact nuclei decreased."
        },
        {
          "Variant": "R1441C",
          "Conclusion": "Induced nuclear shrinkage. Induced significant cell death (P < 0.001 by ANOVA compared to wild type).",
          "Molecular Effect": "N.D.",
          "Result Description": "Nuclear morphology changes were observed. Counts of cells with intact nuclei decreased."
        },
        {
          "Variant": "Kinase - dead Y1699C",
          "Conclusion": "Decreased the amount of cell death. Delayed cell death compared to kinase - active form. Decreased the number of transfected TUNEL - positive cells to the same level as wild - type protein (P < 0.01 by ANOVA compared to Y1699C).",
          "Molecular Effect": "N.D.",
          "Result Description": "Fewer cells showed nuclear shrinkage. Lower number of TUNEL - positive cells."
        },
        {
          "Variant": "Kinase - dead R1441C",
          "Conclusion": "Decreased the amount of cell death. Delayed cell death compared to kinase - active form.",
          "Molecular Effect": "N.D.",
          "Result Description": "Fewer cells showed nuclear shrinkage. Counts of cells with intact nuclei were higher compared to kinase - active R1441C."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Four replicate transfections were used for SH - SY5Y cells. Four primary cultures were used per construct for primary rat cortical neurons."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Two - way ANOVA was used to analyze the effects of constructs and time for SH - SY5Y cells. One - way ANOVA was used to analyze the effects of constructs for primary rat cortical neurons."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}